Corcoran Andrea — SEC Form 4 filings
SEC reporting owner CIK 1296996. 4 Form 4 filings on record with FilingPulse; latest filed 2026-03-13.
Transaction summary — filings shown
Covers all 4 filings on record, filed 2024-02-02 to 2026-03-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 15,843 shares, $60,915 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: sale of 15,843 shares @ $3.84 ($60,915) in Atea Pharmaceuticals, Inc., filed 2024-02-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Atea Pharmaceuticals, Inc. (AVIR) | See Remarks | 4 | — | 1 leg · 15,843 sh · $60,915 | 16 |
Form 4 filings — Corcoran Andrea
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-13 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Option exercise (M): 60,000 @ $1.24 · Option exercise (M): 60,000 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Option exercise (M): 54,866 · Tax withholding (F): 16,104 @ $4.24 · Option exercise (M): 44,366 (derivative) @ $0 · Option exercise (M): 10,500 (derivative) @ $0 · Grant/award (A): 180,000 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Option exercise (M): 44,367 · Grant/award (A): 10,500 · Tax withholding (F): 16,102 @ $3.06 · Option exercise (M): 44,367 (derivative) @ $0 · Grant/award (A): 10,500 (derivative) @ $0 · Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2024-02-02 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Option exercise (M): 44,367 · Sale (S): 15,843 @ $3.84 · Option exercise (M): 44,367 (derivative) @ $0 · Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1296996 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →